51
|
Nicosia L, Franzese C, Mazzola R, Franceschini D, Rigo M, D'Agostino G, Corradini S, Scorsetti M, Alongi F. A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
52
|
De Rose F, Cozzi L, Meattini I, Fogliata A, Franceschini D, Franzese C, Tomatis S, Becherini C, Livi L, Scorsetti M. The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study. Clin Oncol (R Coll Radiol) 2019; 32:26-34. [PMID: 31377082 DOI: 10.1016/j.clon.2019.07.016] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 06/13/2019] [Accepted: 07/18/2019] [Indexed: 10/26/2022]
Abstract
AIMS To investigate the role of intensity-modulated proton therapy (IMPT) for regional nodal irradiation in patients with breast carcinoma in comparison with volumetric-modulated arc therapy (VMAT). MATERIALS AND METHODS A cohort of 20 patients (10 in the breast-conserving surgery group and 10 post-mastectomy patients with tissue expander implants) was investigated. Proton plans were also computed using robust optimisation methods. Plan quality was assessed by means of dose-volume histograms and scored with conventional metrics. Estimates of the risk of secondary cancer induction (excess absolute risk, EAR) were carried out, taking into account fractionation, repopulation and repair. RESULTS Concerning target coverage, the data proved a substantial equivalence of VMAT and IMPT: for example, coverage for the 50 Gy target, expressed in terms of V98%, was 47.8 ± 0.4, 47.6 ± 0.4, 47.3 ± 0.8, consistent with the objective of 47.5 Gy, for post-mastectomy patients for the three groups of patients. Also, the conformality of the dose distributions was similar for the two techniques, about 1.1, without statistically significant differences. Organ at risk planning aims were achieved for all structures for both techniques. The mean dose to the ipsilateral lung was 10.8 ± 1.1, 6.2 ± 0.8, 7.2 ± 1.0; for the contralateral lung was 3.2 ± 0.7, 0.3 ± 0.2, 0.4 ± 0.2; for the contralateral breast was: 3.1 ± 0.7, 0.3 ± 0.3 and 0.3 ± 0.3, whereas it was 3.9 ± 0.9, 0.4 ± 0.3 and 0.5 ± 0.5, respectively, for the heart for VMAT, IMPT and robust IMPT plans over the whole group of patients. Robust optimisation affected the near-to-maximum dose values for contralateral lung and breast, the mean dose for the heart and ipsilateral lung, with a deterioration ranging from 20 to 40% of the nominal value of IMPT plans (e.g. from 8.1 ± 6.4 to 11.4 ± 8.8 for the heart compared with 16.2 ± 5.2 for the VMAT plans). The numerical values of EAR per 10 000 patient-years were about one order of magnitude higher for VMAT than for IMPT for contralateral structures: 11.66 ± 2.01, 0.89 ± 0.80, 0.98 ± 0.77 for the contralateral breast and the three groups of plans, respectively; 14.31 ± 2.75, 1.42 ± 0.80, 1.78 ± 0.87 for the contralateral lung; and 34.86 ± 2.64, 18.85 ± 2.15, 20.98 ± 2.35 for the ipsilateral lung. CONCLUSION IMPT with or without robust optimisation seems to be a potentially promising approach for the radiation treatment of breast cancer when nodal volumes should be irradiated. This was measured in terms of dosimetric advantage and predicted clinical benefit. In fact, the significant reduction in estimated EAR could add further clinical value to the dosimetric sparing of the organs at risk achievable with IMPT.
Collapse
|
53
|
Scorsetti M, Comito T, Franzese C, Franceschini D, De Rose F, Tomatis S, D’alessio A, Prete M, Bozzarelli S, Rimassa L, Personeni N, Santoro A. Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer: single institution experience. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
54
|
Agostinetto E, Masci G, Giordano L, Losurdo A, De Sanctis R, Torrisi R, Zuradelli M, Scorsetti M, Santoro A. HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz100.037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
55
|
Franceschini D, Bianciardi F, Mazzola R, De Rose F, Gentile P, Alongi F, Scorsetti M. PO-0876 Stereotactic Body Radiation Therapy for thoracic nodes metastases, a multi-institutional experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31296-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
56
|
Franzese C, Fogliata A, Franceschini D, De Rose F, Comito T, Navarria P, Cozzi L, Tomatis S, Scorsetti M. EP-1171 Toxicity profile of locally advanced head and neck cancer patients treated in 30 or 33 fractions RT. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31591-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
57
|
Tomatis S, Esposito E, Gaudino A, Lobefalo F, Mancosu P, Paganini L, Palumbo V, Stravato A, Tomatis E, Rossi M, Merati E, De rose F, Reggiori G, Scorsetti M. EP-1916 Predictive model of the dose to the heart based on geometry evaluation in left breast radiotherapy. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32336-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
58
|
Cozzi L, Comito T, Fogliata A, Franzese C, Franceschini D, Bonifacio C, Tozzi A, Di Brina L, Clerici E, Tomatis S, Reggiori G, Lobefalo F, Stravato A, Mancosu P, Zerbi A, Sollini M, Margarita K, Chiti A, Scorsetti M. PO-0955 Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31375-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
59
|
Tozzi A, Iftode C, Cozzi S, D'Agostino G, Franzese C, Di Brina L, Comito T, De Rose F, Renna I, Franceschini D, Navarria P, Clerici E, Mancosu P, Lobefalo F, Stravato A, Scorsetti M. EP-1457 Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31877-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
60
|
Alongi F, Nicosia L, Francese C, D'Agostino G, Di Brina L, Figlia V, Mazzola R, Tomatis S, Scorsetti M. EP-1559 SBRT for lymph node metastases from prostate cancer: a multi-institutional retrospective analysis. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31979-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
61
|
Fogliata A, Reggiori G, Franzese C, Franceschini D, Tomatis S, Scorsetti M, Cozzi L. PO-0925 On the ability of a knowledge based planning process to improve itself. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31345-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
62
|
Franzese C, Comito T, Tozzi A, De Rose F, Navarria P, Mancosu P, Tomatis S, Scorsetti M. PO-0883 Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31303-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
63
|
Di Brina L, Navarria P, D'Agostino G, De Rose F, Iftode C, Clerici E, Lobefalo F, Bertuzzi A, Quagliuolo V, Scorsetti M. EP-1605 Adjuvant RT for soft tissue sarcomas: volumetric modulated arc therapy vs 3D conformal radiotherapy. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32025-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
64
|
Mancosu P, Reggiori G, Gaudino A, Lobefalo F, Paganini L, Palumbo V, Stravato A, Tomatis S, Scorsetti M. PO-0936 To be or not to be homogeneous in SBRT plans? a systematic multi-planning study. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31356-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
65
|
Cozzi L, Comito T, Fogliata A, Franzese C, Tomatis S, Scorsetti M. EP-1850 Intensity modulated protons: feasibility for hypofractionated hepatocellular carcinoma treatment. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32270-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
66
|
Iftode C, Tozzi A, D'Agostino G, Comito T, Franzese C, De Rose F, Franceshini D, Di Brina L, Navarria P, Clerici E, Tomatis S, Scorsetti M. EP-1493 SBRT for oligometastatic gynecological cancer: a single institution experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31913-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
67
|
Comito T, Franzese C, Clerici E, Navarria P, D'Agostino G, Carrara S, Rimassa L, Tomatis S, Zerbi A, Scorsetti M. EP-1430 Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31850-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
68
|
Paganini L, Reggiori G, Stravato A, Palumbo V, Mancosu P, Lobefalo F, Gaudino A, Tomatis S, Scorsetti M. EP-1772 MLC parameters evaluation in a RT-dedicated MC environment (PRIMO) from static fields to VMAT plans. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32192-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
69
|
D'Agostino G, Di Brina L, Franzese C, Tomatis S, Iftode C, Franceschini D, Clerici E, Reggiori G, Tozzi A, Navarria P, Scorsetti M. External Beam Re-Irradiation of Locally Recurrent Prostate Cancer with FFF-VMAT. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
70
|
Franceschini D, De Rose F, Radicioni G, Toska E, Faraci L, Carta G, Scorsetti M. P3.08-02 Oligometastatic Non Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT), a Single Institution Experience. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
71
|
Pessina F, Navarria P, Clerici E, Carta G, Scorsetti M, Bello L. P05.36 Skull base meningiomas: prognostic factors analysis for recurrence with multimodality treatment. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
72
|
Navarria P, Clerici E, Pessina F, Franzese C, Bello L, Simonelli M, Tomatis S, Leonetti A, Scorsetti M. P01.073 Hypofractionated radiation therapy (over 3 weeks) can replace conventional radiation therapy schedule (over 6 weeks) in newly diagnosed glioblastoma patients? The times are ripe. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
73
|
Navarria P, Clerici E, Pessina F, Franzese C, Bello L, Riva M, Toschi L, Masci G, Comito T, Scorsetti M. P05.75 Surgery followed by fractionated radiosurgery on the tumor bed in patients with single large brain metastases from solid tumor: preliminary results of a phase II study. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
74
|
Franzese C, Navarria P, Clerici E, Comito T, Pessina F, Bello L, Reggiori G, Tomatis S, Scorsetti M. P05.50 Hypofractionated stereotactic radiation therapy (HSRT) in skull base meningiomas. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
75
|
Pessina F, Navarria P, Conti Nibali M, Riva M, Carta G, Clerici E, Simonelli M, Rudà R, Scorsetti M, Bello L. P01.043 Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assesment. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|